Department of Laboratory Medicine, Jiangnan University Medical Center (Wuxi No People's Hospital), 68 Zhongshan Road, Wuxi, Jiangsu, 214000, China.
Human reproductive medicine center, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi, Jiangsu, 214026, China.
BMC Cancer. 2024 May 7;24(1):568. doi: 10.1186/s12885-024-12329-z.
The index composed of preoperative lymphocytes, albumin, and neutrophils (LANR), a new composite score based on inflammatory response and nutritional status, has been reported to be associated with the prognosis of multiple types of cancer, but the role of LANR in the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) has not yet been elucidated.
The data of 142 patients with PDAC who underwent radical resection in the Affiliated Hospital of Jiangnan University from January 2015 to December 2018 were retrospectively analyzed. Receiver Operating Characteristic (ROC) curves were generated to determine the optimal cut-off values for these parameters, as well as the sensitivity and specificity of LANR in predicting survival. The Kaplan-Meier method was used to draw the survival curves. Log rank test was used for univariate analysis, and Cox proportional hazards regression model was used for multivariate analysis. RESULTS: The optimal cut-off value of LANR was 18.145, and a low preoperative LANR was significantly correlated with the location of the tumor (p = 0.047). Multivariate analysis showed that tumor differentiation degree (HR:2.357, 95%CI:1.388-4.003,p = 0.002), lymph node metastasis (HR:1.755, 95%CI: 1.115-2.763, p = 0.015), TNM stage (HR:4.686, 95%CI: 2.958-7.425, p < 0.001), preoperative cancer antigen 19 - 9 levels (HR:1.001, 95%CI: 1.000-1.001, p < 0.001) and preoperative LANR (HR:0.221, 95%CI: 0.111-0.441, p < 0.001) were independent risk factors for a poor prognosis in patients undergoing radical resection of PDAC.
This study found that preoperative LANR can be used to assess the prognosis of radical resection in patients with PDAC; those with low preoperative LANR had a worse outcome.
基于炎症反应和营养状况的新复合评分——术前淋巴细胞、白蛋白和中性粒细胞指数(LANR),已被报道与多种类型癌症的预后相关,但 LANR 在可切除胰腺导管腺癌(PDAC)预后中的作用尚未阐明。
回顾性分析了 2015 年 1 月至 2018 年 12 月在江南大学附属医院接受根治性切除术的 142 例 PDAC 患者的数据。生成受试者工作特征(ROC)曲线,以确定这些参数的最佳截断值,以及 LANR 预测生存的灵敏度和特异性。采用 Kaplan-Meier 法绘制生存曲线。对数秩检验用于单因素分析,Cox 比例风险回归模型用于多因素分析。
LANR 的最佳截断值为 18.145,术前低 LANR 与肿瘤位置显著相关(p=0.047)。多因素分析显示肿瘤分化程度(HR:2.357,95%CI:1.388-4.003,p=0.002)、淋巴结转移(HR:1.755,95%CI:1.115-2.763,p=0.015)、TNM 分期(HR:4.686,95%CI:2.958-7.425,p<0.001)、术前癌抗原 19-9 水平(HR:1.001,95%CI:1.000-1.001,p<0.001)和术前 LANR(HR:0.221,95%CI:0.111-0.441,p<0.001)是 PDAC 根治性切除术后预后不良的独立危险因素。
本研究发现术前 LANR 可用于评估 PDAC 根治性切除术后的预后;术前 LANR 较低的患者预后较差。